IRIS Institutional Research Information System - OPENBS Open Archive UniBS

TINCANI, Angela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.426
EU - Europa 16.310
AS - Asia 5.820
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 41
OC - Oceania 41
SA - Sud America 41
Totale 49.748
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.341
IT - Italia 3.988
UA - Ucraina 3.939
CN - Cina 3.589
DE - Germania 2.992
PL - Polonia 1.750
HK - Hong Kong 1.169
FI - Finlandia 888
IE - Irlanda 684
GB - Regno Unito 680
SG - Singapore 627
FR - Francia 569
RU - Federazione Russa 373
SE - Svezia 181
IN - India 162
TR - Turchia 72
CA - Canada 61
VN - Vietnam 60
NL - Olanda 45
ES - Italia 44
EU - Europa 41
AU - Australia 40
BE - Belgio 32
RO - Romania 27
CZ - Repubblica Ceca 23
CH - Svizzera 19
EG - Egitto 18
BR - Brasile 17
KR - Corea 17
GR - Grecia 15
IR - Iran 15
JP - Giappone 15
IL - Israele 14
LB - Libano 14
MA - Marocco 12
MU - Mauritius 12
MX - Messico 10
TH - Thailandia 10
TN - Tunisia 10
DK - Danimarca 7
DZ - Algeria 7
ID - Indonesia 7
MK - Macedonia 7
SK - Slovacchia (Repubblica Slovacca) 7
AE - Emirati Arabi Uniti 6
AR - Argentina 6
CO - Colombia 6
UY - Uruguay 6
AT - Austria 5
BG - Bulgaria 5
BS - Bahamas 5
HU - Ungheria 5
PH - Filippine 5
GE - Georgia 4
IQ - Iraq 4
LU - Lussemburgo 4
MY - Malesia 4
PT - Portogallo 4
RS - Serbia 4
SA - Arabia Saudita 4
AM - Armenia 3
KZ - Kazakistan 3
LI - Liechtenstein 3
SI - Slovenia 3
AL - Albania 2
CL - Cile 2
CR - Costa Rica 2
JM - Giamaica 2
JO - Giordania 2
LY - Libia 2
NP - Nepal 2
PE - Perù 2
PK - Pakistan 2
TW - Taiwan 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BF - Burkina Faso 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GT - Guatemala 1
HN - Honduras 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LT - Lituania 1
MS - Montserrat 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
SN - Senegal 1
UG - Uganda 1
UZ - Uzbekistan 1
Totale 49.746
Salva come PNG Salva come JPEG
Città #
Fairfield 4.290
Woodbridge 3.995
Jacksonville 2.811
Houston 2.706
Ashburn 1.866
Ann Arbor 1.750
Warsaw 1.740
Cambridge 1.644
Seattle 1.620
Wilmington 1.511
Princeton 1.215
Hong Kong 1.159
Nanjing 928
Chandler 752
Dublin 621
Beijing 521
New York 463
Helsinki 427
Singapore 381
Nanchang 354
Milan 323
Des Moines 282
Shenyang 247
Hebei 230
San Diego 230
Changsha 209
Brescia 183
Rome 153
Tianjin 152
Jiaxing 147
Lancaster 135
Jinan 125
Shanghai 124
Verona 115
Nürnberg 102
Florence 101
London 99
Kunming 86
Hangzhou 84
Dearborn 60
Trieste 53
Kocaeli 49
San Francisco 49
Lanzhou 48
Ningbo 48
Dong Ket 47
Boardman 46
Zhengzhou 43
Los Angeles 41
Toronto 40
Bergamo 39
Munich 39
Taizhou 38
Udine 36
Guangzhou 34
Haikou 34
Norwalk 33
Redwood City 33
Turin 33
Brussels 31
Genoa 31
Padova 31
Bologna 30
Syracuse 30
Orange 29
Changchun 28
Genova 25
Pisa 25
Menlo Park 22
Mumbai 22
Reggio Nell'emilia 20
Strasbourg 20
Taiyuan 20
Brno 19
Kilburn 19
Augusta 18
Melbourne 18
Paris 17
Pune 17
Torino 17
San Mateo 16
Hounslow 15
Trento 14
Bari 13
Beirut 13
Fuzhou 13
Palermo 13
Acton 12
Chiswick 12
Ferrara 12
Hanover 12
Modena 12
Napoli 12
Prescot 12
Seongnam 12
Catania 11
Chicago 11
Dallas 11
Falkenstein 11
Perugia 11
Totale 35.461
Salva come PNG Salva come JPEG
Nome #
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 2.016
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.478
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). 662
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 248
Reduced T-cell repertoire restrictions in abatacept-treated rheumatoid arthritis patients. 248
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome 241
9A.07: CARDIOVASCULAR TARGET ORGAN DAMAGE IN PREMENOPAUSAL SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AND IN CONTROLS. ARE THERE ANY DIFFERENCES? 238
Abatacept reduces levels of switched memory B cells, autoantobodies, and immunoglobulins in patients with Rheumatoid Arthritis 225
The Pathogenicity of Anti-β2GP1-IgG Autoantibodies Depends on Fc Glycosylation 202
Preface. What's New in Autoimmunity: New Autoantibodies, New Therapies, New Diseases 198
Transverse Myelitis Activation Post-H1N1 Immunization: A Case of Adjuvant Induction? 193
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. 185
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. 182
Long-term outcome of children of rheumatic disease patients 171
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI E LESIONI PUNTIFORMI DELLA SOSTANZA BIANCA ALLA RISONANZA MAGNETICA. QUAL E' IL LORO SIGNIFICATO? VALUTAZIONE DI 169 PAZIENTI CON MANIFESTAZIONI NEUROLOGICHE 161
Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder? 161
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 156
Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis 154
Failure of intravenous immunoglobulin to prevent congenital heartblock: Findings of a multicenter, prospective, observational study 153
Antirheumatic drugs and reproduction in women and men with chronic arthritis. 152
Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens. 152
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 148
14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome 148
Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells. 146
Cutaneous distribution of plasmacytoid dendritic cells in lupus erythematosus. Selective tropism at the site of epithelial apoptotic damage 145
Microvascular Density and Circulating Endothelial Progenitor Cells Before and After Treatment with Incretin Mimetics in Diabetic Patients 145
Typing TREX1 Gene In Patients With Systemic Lupus Erythematosus. 140
14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends 140
The role of second trimester uterine artery Doppler in pregnancies with systemic lupus erythematosus 132
Effect of short-term treatment with lercanidipine on circulating endothelial progenitor cells and structural alterations in retinal arterioles 132
Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression 129
Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome 128
Patients with longstanding primary antiphospholipid syndrome: retrospective analysis of organ damage and mortality 127
Anti-cardiolipin and anti-beta2-glycoprotein I antibodies: performance of new commercial ELISA kits. 126
Anti-IFI16 antibodies and their relation to disease characteristics in systemic lupus erythematosus. 126
Antiphospholipid antibodies mediate autoimmunity against dying cells. 124
A 24-month prospective study on the efficacy and safety of two different monthly regimens of vitamin D supplementation in pre-menopausal women with systemic lupus erythematosus 124
A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus 124
Inflammatory molecules: A target for treatment of systemic autoimmune diseases. 122
Children born to SLE and APS mothers 122
Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes 121
Anti-phospholipid antibodies 120
Systemic lupus erythematosus and endothelial dysfunction: A close relationship 119
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 119
Management of thrombotic and obstetric antiphospholipid syndrome: A systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults 119
Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events 118
25 years of the antiphospholipid syndrome: lights and shadows on the primary prophylaxis of asymptomatic patients with confirmed positivity of antiphospholipid antibodies. 117
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 117
The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes 117
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 117
New acquirements on an old molecule: type I interferon. 115
Management of recurrent thrombosis in antiphospholipid syndrome 115
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis 115
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 114
Forum interdisciplinare per la ricerca delle malattie autoimmuni (FIRMA) study group. Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study. 113
Decreased circulating t regulatory lymphocytes in obese patients undergoing bariatric surgery 113
Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity? 112
Much more than thrombosis and pregnancy loss: the antiphospholipid syndrome as a 'systemic disease'. 112
Treatment and functional outcome of patients with cystoid macular edema: a single-center experience 112
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 112
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome 112
V meeting of the European forum on antiphospholipid antibodies. 111
Should our approach to the anticardiolipin assay change 20 years after its discovery? 111
Pregnancy in autoimmune rheumatic diseases: the importance of counselling for old and new challenges. 111
Beyond the "syndrome": antiphospholipid antibodies as risk factors. 111
Brief Report: Successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: An Italian multicenter study 111
Relationship Between Different Subpopulations of Circulating CD4+ T-lymphocytes and Microvascular Structural Alterations in Humans 111
Autoimmune polyendocrine Syndromes 110
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab 110
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 110
State of the art: Reproduction and pregnancy in rheumatic diseases. 109
Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin D 109
Endothelial Dysfunction In Early Systemic Lupus Erythematosus Patients And Controls Without Previous Cardiovascular Events. 109
Follow up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation 108
APS ACTION--AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal Networking. 108
Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. 107
Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. 107
Are the current attempts at standardization of antiphospholipid antibodies still useful? Emerging technologies signal a shift in direction. 106
Antiphospholipid antibody profile: implications for the evaluation and management of patients. 106
Endothelium and the brain in CNS lupus. 106
High intensity anticoagulation in the prevention of the recurrence of arterial thrombosis in antiphospholipid syndrome: 'PROS' and 'CONS'. 106
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera 106
Laboratory criteria of the obstetrical antiphospholipid syndrome. Data from a multicentric prospective European women cohort. 105
Neonatal effects of maternal antiphospholipid syndrome. 105
Exploring Autoimmunity in a Cohort of Children with Genetically Confirmed Aicardi–Goutières Syndrome 105
Long-term neurodevelopmental outcome of children born to prospectively followed pregnancies of women with systemic lupus erythematosus and/or antiphospholipid syndrome 105
Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis 105
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: Comment on the article by Rudominer et al. 104
Development of automated assays for anticardiolipin antibodies determination: addressing antigen and standardization issues. 104
Involvement of renal tubular Toll-like receptor 9 in the development of tubulointerstitial injury in systemic lupus. 104
Aspirin-interleukin-3 interrelationships in patients with anti-phospholipid syndrome. 104
Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study 104
Longterm outcome of patients with primary antiphospholipid syndrome: A retrospective multicenter study 104
Pregnancy complications of the antiphospholipid syndrome 103
Pregnancy, lupus and antiphospholipid syndrome (Hughes syndrome). 103
Treatment of lupus skin involvement with quinacrine and hydroxychloroquine. 103
Evaluation of mortality, disease activity, treatment, clinical and immunological features of adult and late onset systemic Lupus erythematosus. 103
Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 103
Rare autoantibodies to cellular antigens in systemic lupus erythematosus. 103
Pregnancy in patients with autoimmune disease: A reality in 2016 103
Totale 16.686
Salva come PNG Salva come JPEG
Categoria #
all - tutte 221.761
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 221.761
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010.759 0 427 505 1.585 751 1.348 1.039 1.390 916 1.571 432 795
2020/20219.196 182 1.128 442 1.079 498 1.118 313 1.084 1.152 949 887 364
2021/20225.232 280 981 159 312 145 300 318 393 290 556 468 1.030
2022/20233.585 702 46 82 180 281 996 41 288 517 54 206 192
2023/20244.337 235 124 327 346 191 637 156 180 1.246 108 90 697
2024/2025225 141 84 0 0 0 0 0 0 0 0 0 0
Totale 50.593